Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-48
Closed -$1.57K 996
2024
Q1
$1.57K Buy
48
+7
+17% +$238 ﹤0.01% 910
2023
Q4
$1.49K Hold
41
﹤0.01% 915
2023
Q3
$1.5K Hold
41
﹤0.01% 948
2023
Q2
$1.57K Buy
41
+20
+95% +$739 ﹤0.01% 936
2023
Q1
$847 Hold
21
﹤0.01% 963
2022
Q4
$717 Buy
+21
New +$734 ﹤0.01% 893
2022
Q2
Sell
-2
Closed 1031
2022
Q1
$0 Buy
+2
New +$86 ﹤0.01% 1044
2020
Q2
Sell
-20
Closed 861
2020
Q1
$0 Hold
20
﹤0.01% 895
2019
Q4
$0 Hold
20
﹤0.01% 923
2019
Q3
$0 Hold
20
﹤0.01% 938
2019
Q2
$0 Buy
+20
New +$411 ﹤0.01% 947
2018
Q2
Sell
-89,270
Closed -$5.33M 346
2018
Q1
$5.33M Sell
89,270
-75,921
-46% -$5.06M 0.22% 89
2017
Q4
$13M Sell
165,191
-3,047
-2% -$246K 0.52% 51
2017
Q3
$14.1M Buy
168,238
+6,862
+4% +$487K 0.61% 48
2017
Q2
$10.6M Buy
161,376
+14,862
+10% +$1.01M 0.48% 59
2017
Q1
$10.6M Buy
146,514
+122,444
+509% +$8.04M 0.49% 59
2016
Q4
$1.41M Buy
+24,070
New +$1.27M 0.07% 161

Other funds holding ADNT

HM Payson & Co's ADNT Position: Q2 2024 in Review

HM Payson & Co sold out of Adient (ADNT) in Q2 2024, closing a stake of 48 shares — an estimated $1.57K sold.

HM Payson & Co first reported a position in ADNT in Q4 2016 and held it in 17 quarters. The position peaked at $14.1M in Q3 2017. 279 funds tracked by Wall St. Rank hold ADNT as of Q2 2024.

  • HM Payson & Co reported no remaining Adient position as of Q2 2024 after selling out during the quarter.
  • HM Payson & Co sold 48 Adient shares in Q2 2024, an estimated $1.57K.
  • HM Payson & Co first reported a position in Adient in Q4 2016 and held it in 17 quarters.
  • HM Payson & Co's Adient position peaked at $14.1M in Q3 2017.
  • 279 funds tracked by Wall St. Rank held Adient as of Q2 2024.

Based on HM Payson & Co's 13F filing for Q2 2024, filed 13 Aug 2024.